← Eichor
Condition: Chronic Inflammatory Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Chronic Inflammatory Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT03913962A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg)
Phase 3 · 129 location(s) · Sanofi · NCT06290141Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi
Phase N/A · 4 location(s) · Meyer Children's Hospital IRCCS · NCT06862843Development of New Diagnostic Tools in Capsule Endoscopy
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06152289Determinants of Chronic Inflammatory Skin Disease Trajectories
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT05928169Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Phase N/A · 23 location(s) · argenx · NCT07264426China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370Combination of Diet and Oral Budesonide for Ulcerative Colitis
NA · 6 location(s) · Wolfson Medical Center · NCT05791487Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT07022197R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Phase 1 · 5 location(s) · Rise Therapeutics LLC · NCT05666960Biobank for Inflammatory Chronic Diseases and Osteoporosis
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05039216An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintena
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03167437Sensory Outcomes in Active Substance Users
Phase N/A · 1 location(s) · Boston Medical Center · NCT06639438Effect of Aronia Berry Consumption on Inflammatory Parameters
NA · 1 location(s) · Amasya University · NCT06702696Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Phase 1/Phase 2 · 1 location(s) · Staci Gruber, Ph.D. · NCT07728695Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intest
Phase N/A · 1 location(s) · IRCCS Ospedale San Raffaele · NCT06516341Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 2/Phase 3 · 118 location(s) · Janssen Research & Development, LLC · NCT05327114Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3 · 1 location(s) · Amsterdam University Medical Center (UMC), Location Academic · NCT06714838Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development
Phase N/A · 3 location(s) · Fundació Sant Joan de Déu · NCT07033663Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases
NA · 1 location(s) · CHU de Reims · NCT02924818Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
Phase 4 · 4 location(s) · University of Aarhus · NCT04589299Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowe
Phase N/A · 1 location(s) · Fondation Lenval · NCT07383844A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · 131 location(s) · Sanofi · NCT06290128Impact of the Therapeutic Education Program "living with a Chronic Inflammatory Disease Under Biotherapy" on Patient Com
Phase N/A · 1 location(s) · Groupe Hospitalier de Bretagne Sud · NCT06620770A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Ca
Phase N/A · 15 location(s) · Takeda · NCT06538064Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP
Phase N/A · 1 location(s) · Sanofi · NCT06968975Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease
Phase N/A · 2 location(s) · Fu Jen Catholic University · NCT07474220
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.